$INO RT @InovioPharma "Today we announced positive efficacy results for our open-label Phase 2 trial of VGX-3100 to treat HPV-16 and HPV-18-associated vulvar dysplasia. Based upon these results INOVIO is planning to pursue Phase 3 development. Read more: ir.inovio.com/news-releases... #DNAMedicine #HPV" #Inovio #Pharmaceuticals #Biotechnology #DNA #Vaccines #Medicines #BioTech #Bullish #Stock #INO
  • 7
  • 1
7 Likes